Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis

L Fu, Y Qian, Z Shang, X Sun, X Kong, Y Gao - Frontiers in medicine, 2022 - frontiersin.org
Drug-induced liver injury (DILI) is a disease that remains difficult to predict and prevent from
a clinical perspective, as its occurrence is hard to fully explain by the traditional …

Interplay between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview

G Li, Y Hou, C Zhang, X Zhou, F Bao, Y Yang… - Cellular and Molecular …, 2024 - Elsevier
Drug-induced liver injury is a prevalent severe adverse event in clinical settings, leading to
increased medical burdens for patients and presenting challenges for the development and …

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study

M Zhao, CF Liu, YF Feng, H Chen - Frontiers in Pharmacology, 2022 - frontiersin.org
Introduction: Polypharmacy are commonly observed among older adults with cardiovascular
disease. However, multiple medications lead to increased risk of drug-drug interactions …

Prevalence and predictors of clinically significant statin–drug interactions among Yemeni patients taking statins for primary and secondary prevention of …

FY Al-Ashwal, SAS Sulaiman… - Current Medical …, 2022 - Taylor & Francis
Background Statins are extensively used in clinical practice for the primary and secondary
prevention of cardiovascular diseases. Statins are usually taken in combination with other …

[PDF][PDF] Analyzing Hepatotoxicity: A Comparative Study of Simvastatin and Rosuvastatin, and Their Reversal Using Montelukast and Coenzyme Q10

S Jahan, M Khan, M Khan, S Zahir, R Syed… - Medical Forum …, 2023 - medforum.pk
Objective: The study aims to compare the hepatotoxic potential simvastatin and rosuvastatin
owing to the lack in knowledge regarding the comparative hepatotoxic potential of the two …